The gonadotrophin-enhancing effect of RCF-2 (prepared from aqueous extracts of rat cerebral tissue) was evaluated in several species of laboratory animals. RCF-2 alone did not induce any discernible gonadal response. Superovulation in immature rats treated with pregnant mare serum (PMS) or a combination of PMS and human chorionic gonadotrophin (HCG) was significantly increased by RCF-2. Ovulation in intact PMS-treated rats was increased to 84–127% above the response of controls. Hypophysectomized or intact rats treated with PMS + HCG shed 34–53% more ova when they were treated with 0·2 mg. RCF-2.
An almost maximal uterine weight response was found in immature mice treated with RCF-2 in combination with subminimally effective doses of HCG. RCF-2 neither induced ovulation in post-partum rabbits nor in PMS-treated rats in which the release of luteinizing hormone was blocked. The results of these studies suggest that fraction RCF-2 does not act centrally to evoke a release of gonadotrophins but probably has a direct ovarian effect.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 1 | 0 | 0 |
PDF Downloads | 1 | 0 | 0 |